2 false false false false false false false false false true false false false false false false No description of principal activity 2022-02-01 Sage Accounts Production Advanced 2021 - FRS102_2021 2,838 305 3,143 1,908 247 2,155 988 930 xbrli:pure xbrli:shares iso4217:GBP 10550948 2022-02-01 2023-01-31 10550948 2023-01-31 10550948 2022-01-31 10550948 2021-02-01 2022-01-31 10550948 2022-01-31 10550948 core:FurnitureFittings 2022-02-01 2023-01-31 10550948 bus:Director1 2022-02-01 2023-01-31 10550948 core:FurnitureFittings 2022-01-31 10550948 core:FurnitureFittings 2023-01-31 10550948 core:WithinOneYear 2023-01-31 10550948 core:WithinOneYear 2022-01-31 10550948 core:ShareCapital 2023-01-31 10550948 core:ShareCapital 2022-01-31 10550948 core:RetainedEarningsAccumulatedLosses 2023-01-31 10550948 core:RetainedEarningsAccumulatedLosses 2022-01-31 10550948 core:FurnitureFittings 2022-01-31 10550948 bus:Director1 2022-01-31 10550948 bus:Director1 2023-01-31 10550948 bus:Director1 2021-01-31 10550948 bus:Director1 2022-01-31 10550948 bus:Director1 2021-02-01 2022-01-31 10550948 bus:SmallEntities 2022-02-01 2023-01-31 10550948 bus:AuditExempt-NoAccountantsReport 2022-02-01 2023-01-31 10550948 bus:FullAccounts 2022-02-01 2023-01-31 10550948 bus:SmallCompaniesRegimeForAccounts 2022-02-01 2023-01-31 10550948 bus:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31
COMPANY REGISTRATION NUMBER: 10550948
Rao Medical Consulting Limited
Filleted Unaudited Financial Statements
31 January 2023
Rao Medical Consulting Limited
Statement of Financial Position
31 January 2023
2023
2022
Note
£
£
Fixed assets
Tangible assets
4
988
930
Current assets
Debtors
5
91
185
Cash at bank and in hand
20,727
15,334
------------
------------
20,818
15,519
Creditors: amounts falling due within one year
6
52,043
47,904
------------
------------
Net current liabilities
31,225
32,385
------------
------------
Total assets less current liabilities
( 30,237)
( 31,455)
------------
------------
Net liabilities
( 30,237)
( 31,455)
------------
------------
Capital and reserves
Called up share capital
2
2
Profit and loss account
( 30,239)
( 31,457)
------------
------------
Shareholders deficit
( 30,237)
( 31,455)
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Rao Medical Consulting Limited
Statement of Financial Position (continued)
31 January 2023
These financial statements were approved by the board of directors and authorised for issue on 18 October 2023 , and are signed on behalf of the board by:
Dr N S Rao
Director
Company registration number: 10550948
Rao Medical Consulting Limited
Notes to the Financial Statements
Year ended 31 January 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is The Old Vicarage, Brigham, Cockermouth, Cumbria, CA13 0XG.
2. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures and fittings
-
20% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
3. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
4. Tangible assets
Fixtures and fittings
£
Cost
At 1 February 2022
2,838
Additions
305
------------
At 31 January 2023
3,143
------------
Depreciation
At 1 February 2022
1,908
Charge for the year
247
------------
At 31 January 2023
2,155
------------
Carrying amount
At 31 January 2023
988
------------
At 31 January 2022
930
------------
5. Debtors
2023
2022
£
£
Other debtors
91
185
------------
------------
6. Creditors: amounts falling due within one year
2023
2022
£
£
Corporation tax
1,210
174
Other creditors
50,833
47,730
------------
------------
52,043
47,904
------------
------------
7. Directors' advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2023
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Dr N S Rao
( 46,770)
( 3,055)
( 49,825)
------------
------------
------------
2022
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Dr N S Rao
( 42,661)
( 4,109)
( 46,770)
------------
------------
------------